Announcement
01 Oct 2020
In October 2020, the Norwegian authorities introduced an export notification on all types of immunoglobulins following the outbreak of COVID-19.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
01 Oct 2020
Revocation date:
03 Mar 2021
Updated: 01 Oct 2020
Export licensing requirement
On 1 October 2020, the Norwegian Medicines Agency introduced an export notification on apixaban and all types of immunoglobulins. Notably, a notification requirement immunoglobulins with the except...
Sign in to see more
Related State Acts
Threads
See all
This state act is not part of any Thread yet.